|
|
The bill that could rock biotech (CNN Money)
Lawmakers are pushing forward with legislation that could help create generic competition for Big Biotech, drastically lowering the costs of expensive biotech drugs and changing the landscape in the pharmaceutical industry forever.
Somerville rolls out biotech welcome mat - Boston Globe
Somerville rolls out biotech welcome matBoston Globe, MA - 3 hours agoKiessling, whose foundation focuses on making stem cell lines out of unfertilized eggs, has become a consultant of sorts to the city as its primary biotech …
Group forms to push biotech in Orlando area - Orlando Sentinel
Group forms to push biotech in Orlando areaOrlando Sentinel, FL - 1 hour ago… for Medical Research would open an East Coast laboratory in Orlando — have generated interest nationwide in the area’s potential as a biotech center. …
Kannapolis seeks $168.4M in biotech bonds - Washington Business Journal
Kannapolis seeks $168.4M in biotech bondsWashington Business Journal, DC - 19 minutes agoThe city of Kannapolis will seek $168.4 million in self-financing bonds to fund projects related to the NC Research Campus. Projects include water lines, …
Industry veteran banks on biotech - NorthJersey.com
Industry veteran banks on biotechNorthJersey.com, NJ - 22 minutes agoAs the former chief executive of Alteon Inc., a biotech developing cardiovascular therapies at its Montvale headquarters, a co-founder of The Liposome Co. …
Biotech sector reaps big bucks in quarter - San Francisco Chronicle
Washington PostBiotech sector reaps big bucks in quarterSan Francisco Chronicle, CA - 31 minutes ago”It was the strongest quarter ever for biotech and medical devices since we started keeping numbers 10 years ago,” said Mark Heesen, president of the …Company coffers get a big boost News & ObserverAustin venture investing nosedives Austin American-Statesman (subscription)Fewer Area Firms Get More Venture Capital Washington PostSeattle Post Intelligencer - WTOPall 69 news articles
EU may take two years to develop biotech crop rules (Reuters via Yahoo! India News)
BRUSSELS (Reuters) - Europe’s farmers will not see any more clarity on EU rules for separating traditional, organic and biotech crops until at least 2009 as experts sift through scientific data on specific plant varieties, officials say.
MedImmune: Biotech On The Block - KIROtv.com
MedImmune: Biotech On The BlockKIROtv.com, WA - 1 hour agoThe Gaithersburg, Md.-based biotech has come under fire from stockholders recently, at the same time its industry is in a frenzy of merger activity. …
TopoTarget of Denmark buys Swiss biotech firm Apoxis for 14.5 … - Pharma Times (subscription)
TopoTarget of Denmark buys Swiss biotech firm Apoxis for 14.5 …Pharma Times (subscription), UK - 1 hour agoDenmark’s TopoTarget has agreed to acquire privately-held Swiss biotechnology firm Apoxis in a share deal, valued at a minimum of 14.5 million euros, …